Barclays’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
11,929
+1,539
| +15% | +$266K | ﹤0.01% | 2211 |
|
|
2025
Q1 | $1.62M | Sell |
10,390
-18,586
| -64% | -$2.9M | ﹤0.01% | 2172 |
|
|
2024
Q4 | $3.99M | Buy |
28,976
+10,240
| +55% | +$1.41M | ﹤0.01% | 1765 |
|
|
2024
Q3 | $2.8M | Sell |
18,736
-268
| -1% | -$40K | ﹤0.01% | 1936 |
|
|
2024
Q2 | $2.59M | Sell |
19,004
-2,068
| -10% | -$282K | ﹤0.01% | 1534 |
|
|
2024
Q1 | $3.19M | Buy |
21,072
+3,747
| +22% | +$566K | ﹤0.01% | 1616 |
|
|
2023
Q4 | $2.18M | Sell |
17,325
-157
| -0.9% | -$19.8K | ﹤0.01% | 2100 |
|
|
2023
Q3 | $1.64M | Buy |
17,482
+16,874
| +2,775% | +$1.58M | ﹤0.01% | 1778 |
|
|
2023
Q2 | $54K | Sell |
608
-68,294
| -99% | -$6.07M | ﹤0.01% | 3642 |
|
|
2023
Q1 | $7.39M | Buy |
68,902
+12,195
| +22% | +$1.31M | ﹤0.01% | 911 |
|
|
2022
Q4 | $6.93M | Sell |
56,707
-68,114
| -55% | -$8.32M | ﹤0.01% | 962 |
|
|
2022
Q3 | $12.9M | Sell |
124,821
-20,223
| -14% | -$2.09M | 0.01% | 735 |
|
|
2022
Q2 | $13.5M | Buy |
145,044
+144,179
| +16,668% | +$13.4M | 0.01% | 719 |
|
|
2022
Q1 | $102K | Buy |
865
+238
| +38% | +$28.1K | ﹤0.01% | 3655 |
|
|
2021
Q4 | $84K | Sell |
627
-34,082
| -98% | -$4.57M | ﹤0.01% | 2983 |
|
|
2021
Q3 | $5.53M | Buy |
34,709
+34,024
| +4,967% | +$5.42M | ﹤0.01% | 1191 |
|
|
2021
Q2 | $90K | Sell |
685
-3,354
| -83% | -$441K | ﹤0.01% | 3172 |
|
|
2021
Q1 | $520K | Sell |
4,039
-298
| -7% | -$38.4K | ﹤0.01% | 2634 |
|
|
2020
Q4 | $723K | Buy |
4,337
+216
| +5% | +$36K | ﹤0.01% | 2143 |
|
|
2020
Q3 | $636K | Buy |
4,121
+138
| +3% | +$21.3K | ﹤0.01% | 2182 |
|
|
2020
Q2 | $589K | Buy |
3,983
+3,654
| +1,111% | +$540K | ﹤0.01% | 2239 |
|
|
2020
Q1 | $37K | Sell |
329
-49
| -13% | -$5.51K | ﹤0.01% | 3208 |
|
|
2019
Q4 | $52K | Sell |
378
-8,233
| -96% | -$1.13M | ﹤0.01% | 3576 |
|
|
2019
Q3 | $829K | Buy |
8,611
+8,313
| +2,790% | +$800K | ﹤0.01% | 2361 |
|
|
2019
Q2 | $34K | Sell |
298
-9,313
| -97% | -$1.06M | ﹤0.01% | 3901 |
|
|
2019
Q1 | $1.13M | Sell |
9,611
-11,022
| -53% | -$1.3M | ﹤0.01% | 2065 |
|
|
2018
Q4 | $1.29M | Buy |
20,633
+15,613
| +311% | +$978K | ﹤0.01% | 1649 |
|
|
2018
Q3 | $356K | Buy |
5,020
+137
| +3% | +$9.72K | ﹤0.01% | 2797 |
|
|
2018
Q2 | $325K | Sell |
4,883
-377
| -7% | -$25.1K | ﹤0.01% | 2508 |
|
|
2018
Q1 | $345K | Buy |
5,260
+560
| +12% | +$36.7K | ﹤0.01% | 2532 |
|
|
2017
Q4 | $188K | Sell |
4,700
-300
| -6% | -$12K | ﹤0.01% | 2685 |
|
|
2017
Q3 | $181K | Buy |
+5,000
| New | +$181K | ﹤0.01% | 2438 |
|